{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:36Z","timestamp":1788307236358,"version":"build-2803163510"},"publisher-location":"Chichester, UK","reference-count":159,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004407.pub2","type":"reference-entry","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T07:54:39Z","timestamp":1128671679000},"source":"Crossref","is-referenced-by-count":52,"title":["Vaccines for measles, mumps and rubella in children"],"prefix":"10.1002","author":[{"given":"Vittorio","family":"Demicheli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Jefferson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rivetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,19]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-1157(89)90031-0","article-title":"Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials","volume":"17","author":"Beck","year":"1989","journal-title":"Journal of Biological Standards"},{"issue":"6834","key":"10.1002\/14651858.CD004407.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/bmj.304.6834.1075","article-title":"Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine","volume":"304","author":"Benjamin","year":"1992","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00006454-199705000-00009","article-title":"Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project","volume":"16","author":"Black","year":"1997","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2125.2003.01790.x","article-title":"MMR vaccine and idiopathic thrombocytopaenic purpura","volume":"55","author":"Black","year":"2003","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-3476(75)80076-X","article-title":"Evaluation of a trivalent measles, mumps, rubella vaccine in children","volume":"87","author":"Bloom","year":"1975","journal-title":"Jouranal of Pediatrics"},{"issue":"31","key":"10.1002\/14651858.CD004407.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1016\/S0264-410X(01)00207-9","article-title":"Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age","volume":"19","author":"Ceyhan","year":"2001","journal-title":"Vaccine"},{"issue":"7-8","key":"10.1002\/14651858.CD004407.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0264-410X(01)00438-8","article-title":"Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain","volume":"20","author":"Cunha","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archpedi.155.3.354","article-title":"Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project","volume":"155","author":"Davis","year":"2001","journal-title":"Archives of Pediatric and Adolescent Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00006454-200206000-00004","article-title":"Childhood vaccinations and risk of asthma","volume":"21","author":"DeStefano","year":"2002","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD004407.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.113.2.259","article-title":"Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta","volume":"113","author":"DeStefano","year":"2004","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/oxfordjournals.aje.a010239","article-title":"Outbreak of aseptic meningitis associated with mass vaccination with a Urabe-containing measles-mumps-rubella vaccine: implications for immunization programs","volume":"151","author":"Dourado","year":"2000","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0033-3506(89)80002-2","article-title":"An evaluation of measles, mumps and rubella vaccine in a population of Yorkshire infants","volume":"103","author":"Dunlop","year":"1989","journal-title":"Public Health"},{"issue":"2","key":"10.1002\/14651858.CD004407.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0033-3506(05)80282-3","article-title":"A randomised single blind trial of a combined mumps measles rubella vaccine to evaluate serological response and reactions in the UK population","volume":"105","author":"Edees","year":"1991","journal-title":"Public Health"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1542\/peds.108.4.e58","article-title":"No evidence for a new variant of measles-mumps-rubella-induced autism","volume":"108","author":"Fombonne","year":"2001","journal-title":"Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD004407.pub2-BIB15|cit15","first-page":"1669","article-title":"Illness after measles-mumps-rubella vaccination","volume":"149","author":"Freeman","year":"1993","journal-title":"CMAJ"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006454-199601000-00010","article-title":"Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-merieux serums et vaccins","volume":"15","author":"Jonville-Bera","year":"1996","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1542\/peds.68.1.18","article-title":"Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27\/3) virus vaccines, singly and in combination","volume":"68","author":"Lerman","year":"1981","journal-title":"Pediatrics"},{"issue":"19","key":"10.1002\/14651858.CD004407.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa021134","article-title":"A population-based study of measles, mumps, and rubella vaccination and autism","volume":"347","author":"Madsen","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1542\/peds.110.5.957","article-title":"Neurologic disorders after measles-mumps-rubella vaccination","volume":"110","author":"Makela","year":"2002","journal-title":"Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD004407.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpedi.1990.02150320069030","article-title":"A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies","volume":"144","author":"Makino","year":"1990","journal-title":"American Journal of Diseases in Children"},{"issue":"1461","key":"10.1002\/14651858.CD004407.pub2-BIB21|cit21","first-page":"69","article-title":"Surveillance of symptoms following MMR vaccine in children","volume":"233","author":"Miller","year":"1989","journal-title":"Practitioner"},{"issue":"12","key":"10.1002\/14651858.CD004407.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/sim.1540","article-title":"Statistical analysis of MMR vaccine adverse events on aseptic meningitis using the case cross-over design","volume":"23","author":"Park","year":"2004","journal-title":"Stat Med"},{"issue":"8487","key":"10.1002\/14651858.CD004407.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(86)91044-5","article-title":"Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins","volume":"1","author":"Peltola","year":"1986","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/adc.63.6.612","article-title":"Serological evaluation of a measles, mumps, and rubella vaccine","volume":"63","author":"Robertson","year":"1988","journal-title":"Archives of Diseases of Children"},{"issue":"12","key":"10.1002\/14651858.CD004407.pub2-BIB25|cit25","first-page":"1408","article-title":"Clinical evaluation of a new measles-mumps-rubella trivalent vaccine","volume":"129","author":"Schwarz","year":"1975","journal-title":"American Journal of Diseases of Children"},{"issue":"9438","key":"10.1002\/14651858.CD004407.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(04)17020-7","article-title":"MMR vaccination and pervasive developmental disorders: a case-control study","volume":"364","author":"Smeeth","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.1971.03190140033006","article-title":"Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies","volume":"218","author":"Stokes","year":"1971","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF01642228","article-title":"Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial","volume":"2","author":"Swartz","year":"1974","journal-title":"Infection"},{"issue":"9169","key":"10.1002\/14651858.CD004407.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(99)01239-8","article-title":"Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.292.3.351","article-title":"MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis","volume":"292","author":"Vestergaard","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD004407.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3181\/00379727-165-40979","article-title":"Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27\/3 rubella virus","volume":"165","author":"Weibel","year":"1980","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00005176-199903000-00032","article-title":"Inflammatory bowel disease, autism, and the measles, mumps, and rubella vaccine","volume":"28","author":"Akobeng","year":"1999","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"2-3","key":"10.1002\/14651858.CD004407.pub2-BIB33|cit33","first-page":"89","article-title":"Summary of clinical studies with the Oka live varicella vaccine produced by Smith Kline-RIT","volume":"27","author":"Andre","year":"1984","journal-title":"Biken J"},{"issue":"42","key":"10.1002\/14651858.CD004407.pub2-BIB34|cit34","first-page":"3822","article-title":"Adverse effects of Virivac","volume":"79","author":"Anonymous","year":"1982","journal-title":"Lakartidningen"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB35|cit35","first-page":"756","article-title":"Vaccination : News on precautions, contraindications, and adverse reactions","volume":"37","author":"Anonymous","year":"1997","journal-title":"Consultant"},{"issue":"11","key":"10.1002\/14651858.CD004407.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00042310-199914110-00004","article-title":"Incidence of measles vaccine-associated adverse events is low","volume":"14","author":"Anonymous","year":"1999","journal-title":"Drugs & Therapy Perspectives"},{"issue":"1-2","key":"10.1002\/14651858.CD004407.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0344-0338(82)80036-8","article-title":"Malignant histiocytosis with slow clinical course","volume":"174","author":"Aozasa","year":"1982","journal-title":"Pathology, Research and Practice"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB38|cit38","first-page":"677","article-title":"Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella","volume":"51","author":"Autret","year":"1996","journal-title":"Therapie"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/rmv.1980050406","article-title":"Complications of mumps vaccines","volume":"5","author":"Balraj","year":"1995","journal-title":"Reviews in Medical Virology"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1542\/peds.88.5.913","article-title":"Egg hypersensitivity and measles-mumps-rubella vaccine administration","volume":"88","author":"Beck","year":"1991","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00006454-199601000-00020","article-title":"Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994)","volume":"15","author":"Beeler","year":"1996","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.pubmed.a042574","article-title":"Adverse reactions and mumps, measles and rubella vaccine","volume":"13","author":"Benjamin","year":"1991","journal-title":"Journal of Public Health Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0092-1157(88)90014-5","article-title":"Interference between strains in live virus vaccines. I: Combined vaccination with measles, mumps and rubella vaccine","volume":"16","author":"Berger","year":"1988","journal-title":"Journal of Biological Standardization"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0092-1157(88)90015-7","article-title":"Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine","volume":"16","author":"Berger","year":"1988","journal-title":"Journal of Biological Standardization"},{"issue":"8338","key":"10.1002\/14651858.CD004407.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(83)92156-6","article-title":"Convulsions after measles immunisation","volume":"1","author":"Berlin","year":"1983","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD004407.pub2-BIB46|cit46","first-page":"983","article-title":"Immunogenicity and reactogenicity of indigenously produced MMR vaccine","volume":"32","author":"Bhargava","year":"1995","journal-title":"Indian PediatrIcs"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/000992287301200311","article-title":"A field trial of combined measles-mumps-rubella vaccine. Satisfactory immunization with 188 children in Chile","volume":"12","author":"Borgono","year":"1973","journal-title":"Clinical Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1399-3038.1997.tb00137.x","article-title":"Measles vaccine in egg allergic children: poor immunogenicity of the Edmoston-Zagreb strain","volume":"8","author":"Bruno","year":"1997","journal-title":"Pediatric Allergy and Immunology"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB49|cit49","first-page":"335","article-title":"Letter: Local subcutaneous atrophy following measles, mumps, and rubella vaccination","volume":"130","author":"Buntain","year":"1976","journal-title":"American Journal of Diseases of Children"},{"issue":"12","key":"10.1002\/14651858.CD004407.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1001\/jama.1969.03150250089009","article-title":"Combined live measles, mumps, and rubella virus vaccines","volume":"207","author":"Buynak","year":"1969","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD004407.pub2-BIB51|cit51","first-page":"801","article-title":"Immunisation problems in measles, rubella and mumps","volume":"25","author":"Chang Hee","year":"1982","journal-title":"Journal of the Korean Medical Association"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0264-410X(91)90053-9","article-title":"Adverse events following measles-mumps-rubella and measles vaccinations in college students","volume":"9","author":"Chen","year":"1991","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00128072-200002040-00004","article-title":"Safety of routine childhood vaccinations. An epidemiological review","volume":"2","author":"Chen","year":"2000","journal-title":"Paediatric Drugs"},{"issue":"Suppl.1","key":"10.1002\/14651858.CD004407.pub2-BIB54|cit54","first-page":"77","article-title":"Effectiveness and security of the trivalent vaccine against measles, parotitis and rubella (MPR)","volume":"97","author":"Chiodo","year":"1992","journal-title":"L'igiene Moderna"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB55|cit55","first-page":"793","article-title":"Aderse reactions following vaccination with two different types of measles mumps-rubella vaccine","volume":"101","author":"Cinquetti","year":"1994","journal-title":"Igiene Moderna"},{"issue":"11","key":"10.1002\/14651858.CD004407.pub2-BIB56|cit56","first-page":"1106","article-title":"Clinical and immunologic valuation of a new triple measles, mumps and rubella vaccine","volume":"41","author":"Contardi","year":"1989","journal-title":"Giornale di Malattie Infettive e Parassitarie"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB57|cit57","first-page":"421","article-title":"A comparative study of 3 different types of trivalent measles-mumps-rubella vaccine","volume":"14","author":"Contardi","year":"1992","journal-title":"Pediatria Medica e Chirurgica"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/1099-1557(200011)9:6<457::AID-PDS529>3.0.CO;2-R","article-title":"Development and evaluation of a standardized questionnaire for identifying adverse events in vaccine clinical trials","volume":"9","author":"Coplan","year":"2000","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"8","key":"10.1002\/14651858.CD004407.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0264-410X(97)00270-3","article-title":"Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases","volume":"16","author":"D'Argenio","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD004407.pub2-BIB60|cit60","first-page":"27","article-title":"Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign","volume":"24","author":"D'Souza","year":"2000","journal-title":"Communicable Diseases Intelligence"},{"issue":"9","key":"10.1002\/14651858.CD004407.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.285.9.1183","article-title":"Time trends in autism and in MMR immunization coverage in California","volume":"285","author":"Dales","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD004407.pub2-BIB62|cit62","first-page":"515","article-title":"Immune reactivity and risk of an undesiderable response after vaccination","volume":"50","author":"Dankova","year":"1995","journal-title":"Ceskoslovensk\u00e1 Pediatrie"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD004407.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1542\/peds.85.4.682","article-title":"Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants","volume":"85","author":"Dashefsky","year":"1990","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.100.5.767","article-title":"MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team","volume":"100","author":"Davis","year":"1997","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004407.pub2-BIB65|cit65","first-page":"111","article-title":"Safety and efficacy of simultaneous administration of measles-mumps-rubella (MMR) with booster doses of diphteria-tetanus-pertussis (TP) and trivalent oral poliovirus (OPV) vaccines","volume":"65","author":"Deforest","year":"1986","journal-title":"Developments in Biological Standardization"},{"issue":"2","key":"10.1002\/14651858.CD004407.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1542\/peds.81.2.237","article-title":"Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines","volume":"81","author":"Deforest","year":"1988","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3476(00)90067-2","article-title":"Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association","volume":"136","author":"DeStefano","year":"2000","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1468-3083.1999.tb00846.x","article-title":"Toxic epidermal necrolysis following morbilli-parotitis-rubella vaccination","volume":"13","author":"Dobrosavljevic","year":"1999","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB69|cit69","first-page":"240","article-title":"An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines","volume":"12","author":"Dos Santos","year":"2002","journal-title":"Revista Panamericana de Salud P\u00fablica"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB70|cit70","first-page":"81","article-title":"Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic","volume":"52","author":"Ehrenkranz","year":"1975","journal-title":"Bulletin of the World Health Organization"},{"issue":"9224","key":"10.1002\/14651858.CD004407.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(05)73170-6","article-title":"The MMR question","volume":"356","author":"Elphinstone","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3476(89)80598-0","article-title":"Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine","volume":"114","author":"Englund","year":"1989","journal-title":"Journal of Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD004407.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/oxfordjournals.aje.a008695","article-title":"Case series analysis of adverse reactions to vaccines: a comparative evaluation","volume":"143","author":"Farrington","year":"1996","journal-title":"American Journal of Epidemiology"},{"issue":"27","key":"10.1002\/14651858.CD004407.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1016\/S0264-410X(01)00097-4","article-title":"MMR and autism: further evidence against a causal association","volume":"19","author":"Farrington","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB75|cit75","first-page":"57","article-title":"MMR safety studies","volume":"20","author":"Fletcher","year":"2001","journal-title":"Adverse Drug Reactions and Toxicological Reviews"},{"key":"10.1002\/14651858.CD004407.pub2-BIB76|cit76","first-page":"42","article-title":"Triple virus vaccination: Study of its efficacy and safety","volume":"12","author":"Garrido Lestache","year":"1992","journal-title":"Pediatrika"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB77|cit77","first-page":"PI33","article-title":"A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism","volume":"10","author":"Geier","year":"2004","journal-title":"Medical Science Monitor"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1542\/peds.88.5.881","article-title":"Risk of seizures after measles-mumps-rubella immunization","volume":"88","author":"Griffin","year":"1991","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB79|cit79","first-page":"38","article-title":"Vaccination against measles, mumps and rubella: Incidence of side effects using different vaccine strains","volume":"44","author":"Grilli","year":"1992","journal-title":"Giornale di Malattie Infettive e Parassitarie"},{"issue":"7","key":"10.1002\/14651858.CD004407.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00006454-199007000-00002","article-title":"Effect of monovalent measles and trivalent measles-mumps-rubella vaccines at various ages and concurrent administration with hepatitis B vaccine","volume":"9","author":"Huang","year":"1990","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB81|cit81","first-page":"A3","article-title":"Pain response to measles-mumps-rubella (MMR) vaccination at 12 months of age: A randomised clinical trial","volume":"39","author":"Ipp","year":"2003","journal-title":"Journal of Paediatrics & Child Health"},{"issue":"9","key":"10.1002\/14651858.CD004407.pub2-BIB82|cit82","first-page":"R93","article-title":"The impact of MMR vaccine on mumps infection in England and Wales","volume":"1","author":"Jones","year":"1991","journal-title":"CDR (London, England: review)"},{"issue":"48","key":"10.1002\/14651858.CD004407.pub2-BIB83|cit83","first-page":"1727","article-title":"Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella","volume":"115","author":"Just","year":"1985","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD004407.pub2-BIB84|cit84","first-page":"85","article-title":"Evaluation of a combined measles-mumps-rubella-chickenpox vaccine","volume":"65","author":"Just","year":"1986","journal-title":"Developments in Biological Standardization"},{"issue":"11","key":"10.1002\/14651858.CD004407.pub2-BIB85|cit85","first-page":"188","article-title":"Immunogenicity of Vaccines. A comparative Study of a mumps-measles-rubella vaccine given with or without oral polio vaccine","volume":"129","author":"Just","year":"1987","journal-title":"Muenchner Medizinische Wochenschrift"},{"issue":"23","key":"10.1002\/14651858.CD004407.pub2-BIB86|cit86","first-page":"446","article-title":"Trivalent vaccines. A comparative study of the immunogenicity of two trivalent mumps-measles-rubella vaccines given with or without diphtheria-tetanus vaccine","volume":"129","author":"Just","year":"1987","journal-title":"M\u00fcnchener Medizinische Wochenschrift"},{"issue":"23","key":"10.1002\/14651858.CD004407.pub2-BIB87|cit87","first-page":"1672","article-title":"Reactions after MMR vaccination","volume":"152","author":"Kaaber","year":"1990","journal-title":"Ugeskrift for Laeger"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ndt\/17.5.941-a","article-title":"Haemolytic uraemic syndrome following mumps, measles, and rubella vaccination","volume":"17","author":"Karim","year":"2002","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"7284","key":"10.1002\/14651858.CD004407.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/bmj.322.7284.460","article-title":"Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis","volume":"322","author":"Kaye","year":"2001","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0002-9394(78)90304-5","article-title":"Optic neuritis complicating measles, mumps, and rubella vaccination","volume":"86","author":"Kazarian","year":"1978","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD004407.pub2-BIB91|cit91","first-page":"221","article-title":"Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants","volume":"69","author":"Kiepiela","year":"1991","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0404.1997.tb00258.x","article-title":"Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls","volume":"96","author":"Kurtzke","year":"1997","journal-title":"Acta Neurologica Scandinavica"},{"issue":"9106","key":"10.1002\/14651858.CD004407.pub2-BIB93|cit93","doi-asserted-by":"crossref","first-page":"905; author rep","DOI":"10.1016\/S0140-6736(98)26012-0","article-title":"Autism, inflammatory bowel disease, and MMR vaccine","volume":"351","author":"Lee","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1590\/S1020-49892002001000006","article-title":"Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine","volume":"12","author":"Lucena","year":"2002","journal-title":"Revista Panamericana de Salud P\u00fablica"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB95|cit95","first-page":"361","article-title":"Clinical analysis of measles, mumps and rubella vaccine meningitis - Comparative study of mumps, mumps meningitis and MMR meningitis","volume":"38","author":"Maekawa","year":"1991","journal-title":"Jikeikai Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB96|cit96","first-page":"R60","article-title":"Meningoencephalitis associated with MMR vaccine","volume":"1","author":"Maguire","year":"1991","journal-title":"CDR (London, England: review)"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB97|cit97","first-page":"466","article-title":"A field study on vaccine efficacy against mumps of three MMR vaccines","volume":"24","author":"Marolla","year":"1998","journal-title":"Rivista Italiana Di Pediatria"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF01719435","article-title":"The incidence of rubella virus infections in Switzerland after the introduction of the MMR mass vaccination programme","volume":"11","author":"Matter","year":"1995","journal-title":"European Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1007326621525","article-title":"Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination","volume":"13","author":"Matter","year":"1997","journal-title":"European Journal of Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0091-6749(83)90438-4","article-title":"The safety of egg-containing vaccines for egg-allergic patients","volume":"71","author":"Miller","year":"1983","journal-title":"Journal of Clinical Immunology"},{"issue":"8851","key":"10.1002\/14651858.CD004407.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0140-6736(93)91069-X","article-title":"Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB102|cit102","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/adc.84.3.227","article-title":"Idiopathic thrombocytopenic purpura and MMR vaccine","volume":"84","author":"Miller","year":"2001","journal-title":"Archives of Diseases in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB103|cit103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/jinf.2001.0930","article-title":"MMR vaccine: review of benefits and risks","volume":"44","author":"Miller","year":"2002","journal-title":"Journal of Infection"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB104|cit104","first-page":"487","article-title":"A study of immunogenicity of measles, mumps and rubella vaccine prepared from human diploid cell","volume":"26","author":"Min","year":"1991","journal-title":"Journal of the Korean Society for Microbiology"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB105|cit105","first-page":"161","article-title":"Studies on live rubella vaccine. V. Quantitative aspects of interference between rubella, measles and mumps viruses in their trivalent vaccine","volume":"17","author":"Minekawa","year":"1974","journal-title":"Biken Journal"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB106|cit106","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ppul.20089","article-title":"Infant immunization and the occurrence of atopic disease in Dutch and German children: A nested case-control study","volume":"38","author":"Mommers","year":"2004","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"10.1002\/14651858.CD004407.pub2-BIB107|cit107","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF02560515","article-title":"Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26)","volume":"27","author":"Nalin","year":"1999","journal-title":"Infection"},{"issue":"7133","key":"10.1002\/14651858.CD004407.pub2-BIB108|cit108","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/bmj.316.7133.715","article-title":"MMR vaccination and autism 1998 [Erratum in: BMJ 1998 Mar 14;316(7134):796]","volume":"316","author":"Nicoll","year":"1998","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD004407.pub2-BIB109|cit109","first-page":"951-4; author r","article-title":"Measles, mumps, and rubella vaccination and autism","volume":"348","author":"Noble","year":"2003","journal-title":"NEJM"},{"issue":"9106","key":"10.1002\/14651858.CD004407.pub2-BIB110|cit110","doi-asserted-by":"crossref","first-page":"906-7; author r","DOI":"10.1016\/S0140-6736(05)70318-4","article-title":"Autism, inflammatory bowel disease, and MMR vaccine","volume":"351","author":"O'Brien","year":"1998","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD004407.pub2-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00006454-200012000-00002","article-title":"Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up","volume":"19","author":"Patja","year":"2000","journal-title":"Pediatic Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD004407.pub2-BIB112|cit112","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mpd.2001.111165","article-title":"Risk of Guillain-Barre syndrome after measles-mumps-rubella vaccination","volume":"138","author":"Patja","year":"2001","journal-title":"Journal of Paediatrics"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB113|cit113","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000080094","article-title":"Childhood Infections as Risk Factors for Multiple Sclerosis: Belgrade Case-Control Study","volume":"23","author":"Pekmezovic","year":"2004","journal-title":"Neuroepidemiology"},{"issue":"9112","key":"10.1002\/14651858.CD004407.pub2-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(98)24018-9","article-title":"No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study","volume":"351","author":"Peltola","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB115|cit115","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1542\/peds.91.4.835","article-title":"Systemic reactions to measles-mumps-rubella vaccine skin testing","volume":"91","author":"Puvvada","year":"1993","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB116|cit116","first-page":"875","article-title":"Simultaneous administration at different dosages of attenuated live virus vaccines against measles, mumps and rubella","volume":"33","author":"Ramos-Alvarez","year":"1976","journal-title":"Bolet\u00edn M\u00e9dico del Hospital Infantil de M\u00e9xico"},{"issue":"9123","key":"10.1002\/14651858.CD004407.pub2-BIB117|cit117","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(05)77837-5","article-title":"Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"352","author":"Sabra","year":"1998","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB118|cit118","first-page":"344","article-title":"Trivalent vaccine against measles, rubella and parotitis : Clinic and serological evaluation","volume":"42","author":"Scarpa","year":"1990","journal-title":"Giornale di Malattie Infettive e Parassitarie"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB119|cit119","first-page":"117","article-title":"Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps","volume":"41","author":"Schettini","year":"1989","journal-title":"Minerva Pediatrica"},{"issue":"12","key":"10.1002\/14651858.CD004407.pub2-BIB120|cit120","first-page":"531","article-title":"The clinico-immunological evaluation of a bivalent vaccine against measles and rubella","volume":"42","author":"Schettini","year":"1990","journal-title":"Minerva Pediatrica"},{"issue":"2-3","key":"10.1002\/14651858.CD004407.pub2-BIB121|cit121","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0264-410X(97)00174-6","article-title":"Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines","volume":"16","author":"Schwarzer","year":"1998","journal-title":"Vaccine"},{"issue":"11","key":"10.1002\/14651858.CD004407.pub2-BIB122|cit122","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/jech.57.11.883","article-title":"Crohn's disease, ulcerative colitis, and measles vaccine in an English population, 1979-1998","volume":"57","author":"Seagroatt","year":"2003","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB123|cit123","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00006454-200206000-00014","article-title":"Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB124|cit124","first-page":"47","article-title":"A sixty day war of words: is MMR linked to autism?","volume":"20","author":"Spitzer","year":"2001","journal-title":"Adverse Drug Reactions and Toxicological Reviews"},{"key":"10.1002\/14651858.CD004407.pub2-BIB125|cit125","first-page":"411","article-title":"Adverse events following immunization with DTP vaccine","volume":"61","author":"Stetler","year":"1985","journal-title":"Developments in Biological Standardization"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB126|cit126","first-page":"314","article-title":"Studies on active immunization in measles, mumps and rubella","volume":"121","author":"Stokes","year":"1967","journal-title":"Johns Hopkins Medical Journal"},{"issue":"20","key":"10.1002\/14651858.CD004407.pub2-BIB127|cit127","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.1994.03510440062034","article-title":"Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine","volume":"271","author":"Stratton","year":"1994","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB128|cit128","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/infdis\/146.5.709","article-title":"Field trial of trivalent measles-rubella-mumps vaccine in Japan","volume":"146","author":"Sugiura","year":"1982","journal-title":"Journal of Infectious Diseases"},{"issue":"8976","key":"10.1002\/14651858.CD004407.pub2-BIB129|cit129","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(95)92311-X","article-title":"Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan","volume":"346","author":"Ueda","year":"1995","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD004407.pub2-BIB130|cit130","first-page":"527","article-title":"Vaccination against measles, mumps and rubella--together or separately?","volume":"95","author":"Vesikari","year":"1979","journal-title":"Duodecim"},{"issue":"9","key":"10.1002\/14651858.CD004407.pub2-BIB131|cit131","first-page":"843","article-title":"Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children","volume":"138","author":"Vesikari","year":"1984","journal-title":"American Journal of Diseases in Children"},{"issue":"9103","key":"10.1002\/14651858.CD004407.pub2-BIB132|cit132","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","article-title":"Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"351","author":"Wakefield","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004407.pub2-BIB133|cit133","first-page":"183","article-title":"Autism, viral infection and measles-mumps-rubella vaccination","volume":"1","author":"Wakefield","year":"1999","journal-title":"Israel Medical Association Journal"},{"issue":"9182","key":"10.1002\/14651858.CD004407.pub2-BIB134|cit134","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(05)75696-8","article-title":"MMR vaccination and autism","volume":"354","author":"Wakefield","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB135|cit135","first-page":"265-83; discuss","article-title":"Measles, mumps, rubella vaccine: through a glass, darkly","volume":"19","author":"Wakefield","year":"2000","journal-title":"Adverse Drug Reactions and Toxicological Reviews"},{"issue":"10","key":"10.1002\/14651858.CD004407.pub2-BIB136|cit136","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/000992287501401009","article-title":"A field with a liver measles-mumps-rubella vaccine","volume":"14","author":"Walters","year":"1975","journal-title":"Clinical Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD004407.pub2-BIB137|cit137","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/archpedi.157.7.628","article-title":"Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence","volume":"157","author":"Wilson","year":"2003","journal-title":"Archives of Pediatric and Adolescent Medicine"},{"issue":"8","key":"10.1002\/14651858.CD004407.pub2-BIB138|cit138","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1212\/WNL.35.8.1176","article-title":"Viral antibodies in twins with multiple sclerosis","volume":"35","author":"Woyciechowska","year":"1985","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD004407.pub2-BIB139|cit139","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005176-199802000-00026","article-title":"Measles vaccination and inflammatory bowel disease in Japanese children","volume":"26","author":"Yamashiro","year":"1998","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD004407.pub2-BIB140|cit140","first-page":"RR","article-title":"Case definitions for infectious conditions under public health surveillance","volume":"46","year":"1997","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1002\/14651858.CD004407.pub2-BIB141|cit141","article-title":"Cochrane Reviewers' Handbook 4.1.6 Updated quarterly","volume-title":"The Cochrane Library","author":"Clarke","year":"2003"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB142|cit142","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2288-1-7","article-title":"Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials","volume":"1","author":"Derry","year":"2001","journal-title":"BMC Medical Research Methodology"},{"issue":"15-16","key":"10.1002\/14651858.CD004407.pub2-BIB143|cit143","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.vaccine.2004.01.017","article-title":"Control without separate controls: evaluation of vaccine safety using case-only methods","volume":"22","author":"Farrington","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD004407.pub2-BIB144|cit144","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/jech.53.1.51","article-title":"Relation between experimental and non-experimental study designs. HB vaccines: a case study","volume":"53","author":"Jefferson","year":"1999","journal-title":"Journal of Epidemiology and Community Health"},{"key":"10.1002\/14651858.CD004407.pub2-BIB145|cit145","article-title":"Stage II Conducting the review : Phase 5 : Study quality assessment","volume-title":"Undertaking Systematic Reviews of Research on Effectiveness. CDR's guidance for carrying out or commissioning reviews. CRD Report No 4","author":"Khan","year":"2001"},{"issue":"16","key":"10.1002\/14651858.CD004407.pub2-BIB146|cit146","doi-asserted-by":"crossref","first-page":"2076-7; author","DOI":"10.1001\/jama.285.16.2076","article-title":"Safety reporting in clinical trials","volume":"285","author":"Kohl","year":"2001","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1002\/14651858.CD004407.pub2-BIB147|cit147","first-page":"355","article-title":"Must we expect an epidemic of measles in the near future in Southern Tyrol?","volume":"115","author":"Kreidl","year":"2003","journal-title":"Wiener Klinische Wochenschrift"},{"key":"10.1002\/14651858.CD004407.pub2-BIB148|cit148","volume-title":"A Dictionary of Epidemiology","author":"Last","year":"2001"},{"issue":"20","key":"10.1002\/14651858.CD004407.pub2-BIB149|cit149","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1001\/jama.284.20.2643","article-title":"Mumps and rubella eliminated from Finland","volume":"284","author":"Peltola","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD004407.pub2-BIB150|cit150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archpedi.1965.02090030401007","article-title":"Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus","volume":"110","author":"Plotkin","year":"1965","journal-title":"American Journal of Diseases in Children"},{"issue":"6","key":"10.1002\/14651858.CD004407.pub2-BIB151|cit151","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.1973.03220330013003","article-title":"Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States","volume":"225","author":"Plotkin","year":"1973","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004407.pub2-BIB152|cit152","first-page":"409","article-title":"Rubella Vaccine","volume-title":"Vaccines","author":"Plotkin","year":"1999"},{"key":"10.1002\/14651858.CD004407.pub2-BIB153|cit153","first-page":"267","article-title":"Mumps Vaccine","volume-title":"Vaccines","author":"Plotkin","year":"1999"},{"key":"10.1002\/14651858.CD004407.pub2-BIB154|cit154","first-page":"222","article-title":"Measles Vaccine","volume-title":"Vaccines","author":"Redd","year":"1999"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004407.pub2-BIB155|cit155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/378092","article-title":"Global measles elimination efforts: the significance of measles elimination in the United States","volume":"189","author":"Strebel","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"21-22","key":"10.1002\/14651858.CD004407.pub2-BIB156|cit156","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.vaccine.2004.02.001","article-title":"Outbreak of mumps in a vaccinated child population: a question of vaccine failure?","volume":"22","author":"Vandermeulen","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD004407.pub2-BIB157|cit157","doi-asserted-by":"crossref","first-page":"363-6; discussi","DOI":"10.1097\/00006454-199805000-00002","article-title":"The interruption of transmission of indigenous measles in the United States during 1993","volume":"17","author":"Watson","year":"1998","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD004407.pub2-BIB158|cit158","unstructured":"Wells GA Shea B O'Connell D Peterson J Welch V Losos M Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses Available from URL : http:\/\/www.Iri.ca\/programs\/ceu\/oxford.htm 2000"},{"issue":"50","key":"10.1002\/14651858.CD004407.pub2-BIB159|cit159","first-page":"429","article-title":"Measles. Progress towards global control and regional elimination, 1998-1999","volume":"74","author":"WHO","year":"1999","journal-title":"Weekly Epidemiology Records"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004407.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004407.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T21:06:05Z","timestamp":1683234365000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004407.pub2"}},"subtitle":[],"editor":[{"given":"Vittorio","family":"Demicheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2005,10,19]]},"references-count":159,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004407.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004407.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2005,10,19]]}}}